Is Bio-Rad a good company to work for?
Employee feedback regarding Bio-Rad Laboratories on major professional and career review platforms generally portrays the organization as a stable, respectable employer with an overall average rating hovering around 3.6 out of 5 stars. Staff members frequently highlight positive aspects such as a collaborative work environment, dedicated and knowledgeable colleagues, solid health and medical benefits, and a strong commitment to scientific integrity within the life sciences sector. On the other hand, common criticisms raised by employees include bureaucratic management structures, limited internal advancement pathways, compensation packages that sometimes lag behind aggressive tech or pharma industry averages, and occasional stress related to corporate restructuring or cost-cutting initiatives.
Related FAQs
BioMarin Pharmaceutical Inc. maintains a specialized global workforce of approximately 3,221 employees.
Store managers and retail unit leaders at Boot Barn earn comprehensive compensation packages consisting of competitive base salaries, performance-based cash bonuses, and store sales incentive commissions.
Market managers, territory sales managers, and regional commercial leads employed by Pernod Ricard earn comprehensive professional compensation packages that reflect responsibilities in global wine and spirits distribution, brand marketing, and ac...
The BMO lawsuit payout refers to the significant legal settlement involving BMO Harris Bank, where it agreed to pay $550 million to resolve litigation brought by a court-appointed receiver related to the Tom Petters Ponzi scheme.
Wall Street financial research analysts tracking Bio-Rad Laboratories (NYSE: BIO) predominantly maintain a consensus "Hold" rating on the stock.
Bio-Rad Laboratories is widely recognized as a highly reputable, established global leader in the life science research and clinical diagnostics markets.
Determining whether Bio-Rad Laboratories (BIO) represents a good stock purchase depends heavily on an investor's time horizon and portfolio strategy.
Yes, Bio-Rad Laboratories, Inc. is a publicly traded corporation listed on the New York Stock Exchange under the ticker symbols BIO for its Class A common stock and BIOL for its Class B common stock.
Yes, Bio-Rad Laboratories is an American multinational corporation headquartered in Hercules, California.
Yes, Bio-Rad Laboratories remains fully operational, active, and highly solvent as a major global leader in life science research and clinical diagnostics.